Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival

Oncogene

Volumn 31, Issue 46, 2012, Pages 4835-4847

  Sadagopan, S ^a   Veettil, M V ^a   Chakraborty, S ^a   Sharma Walia, N ^a   Paudel, N ^a   Bottero, V ^a   Chandran, B ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

angiogenin; anti apoptosis; cancer; KSHV; p53; p53 ubiquitination

Indexed keywords

ANGIOGENIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; COLON CARCINOMA; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION; HCT116 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; RIBONUCLEASE, PANCREATIC; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

HUMAN HERPESVIRUS 8; MUS;

EID: 84869504554     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.648     Document Type: Article

References (40)

1. Adams JM, Cory S. (2007). Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 19:488-496. (Pubitemid 47487452)
2. Antonsson B, Montessuit S, Sanchez B, Martinou JC. (2001). Bax is present as a high molecular weight oligomer/complex in the mitochon-drial membrane of apoptotic cells. J Biol Chem 276:11615-11623.
3. Ashkenazi A, Dixit VM. (1998). Death receptors: signaling and modulation. Science 281:1305-1308. (Pubitemid 28406815)
4. Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S et al. (1997). Angiogenic protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 3:1579-1586. (Pubitemid 27431566)
5. Chopra V, Dinh TV, Hannigan EV. (1997). Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol 123:167-172. (Pubitemid 27153355)
6. Chopra V, Dinh TV, Hannigan EV. (1998). Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 16:152-159. (Pubitemid 28158437)
7. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF et al. (1985). Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480-5486. (Pubitemid 16228828)
8. Foulkes WD. (2007). p53-master and commander. N Engl J Med 357:2539-2541.
9. Gottlieb TM, Leal JF, Seger R, Taya Y, Oren M. (2002). Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 21:1299-1303. (Pubitemid 34185247)
10. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100:57-70. (Pubitemid 30046295)
11. Haupt Y, Maya R, Kazaz A, Oren M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387:296-299. (Pubitemid 27220766)
12. Hemann MT, Lowe SW. (2006). The p53-Bcl-2 connection. Cell Death Differ 13:1256-1259. (Pubitemid 44057454)
13. Hu F, Gartenhaus RB, Eichberg D, Liu Z, Fang HB, Rapoport AP et al. (2010). PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene 29:5464-5474.
14. Hu GF. (1998). Neomycin inhibits angiogenin-induced angiogenesis. Proc Natl Acad Sci USA 95:9791-9795.
15. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. (2005). Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24:445-456. (Pubitemid 40188592)
16. Kroemer G, Zamzami N, Susin SA. (1997). Mitochondrial control of apoptosis. Immunol Today 18:44-51. (Pubitemid 27072433)
17. Kubbutat MH, Jones SN, Vousden KH. (1997). Regulation of p53 stability by Mdm2. Nature 387:299-303. (Pubitemid 27220767)
18. Li D, Bell J, Brown A, Berry CL. (1994). The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 172:171-175. (Pubitemid 24098668)
19. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, Liu WB et al. (2006). Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene 25:3006-3022. (Pubitemid 43780465)
20. Liu S, Yu D, Xu ZP, Riordan JF, Hu GF. (2001). Angiogenin activates Erk1/2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 287:305-310. (Pubitemid 32912500)
21. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-157. (Pubitemid 26256586)
22. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. (2007). Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26:923-934.
23. Meek DW. (1994). Post-translational modification of p53. Semin Cancer Biol 5:203-210. (Pubitemid 124006730)
24. Milczarek GJ, Martinez J, Bowden GT. (1997). p53 Phosphorylation: biochemical and functional consequences. Life Sci 60:1-11.
25. Montero S, Guzman C, Cortes-Funes H, Colomer R. (1998). Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res 4:2161-2168. (Pubitemid 28415663)
26. Moroianu J, Riordan JF. (1994). Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA 91:1677-1681. (Pubitemid 24080268)
27. Olson KA, French TC, Vallee BL, Fett JW. (1994). A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res 54:4576-4579. (Pubitemid 24276474)
28. Oltvai ZN, Milliman CL, Korsmeyer SJ. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619. (Pubitemid 23259742)
29. Perfettini JL, Castedo M, Nardacci R, Ciccosanti F, Boya P, Roumier T et al. (2005). Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 201:279-289. (Pubitemid 40189437)
30. Riley T, Sontag E, Chen P, Levine A. (2008). Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9:402-412. (Pubitemid 351574202)
31. Sadagopan S, Sharma-Walia N, Veettil MV, Bottero V, Levine R, Vart RJ et al. (2009). Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal micro-vascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J Virol 83:3342-3364.
32. Sadagopan S, Valiya Veettil M, Paudel N, Bottero V, Chandran B. (2011). Kaposi's sarcoma-associated herpesvirus-induced angiogen-in plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. J Virol 85:2666-2685.
33. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. (2000). The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphor-ylate p53 at multiple DNA damage-inducible sites. Genes Dev 14:289-300. (Pubitemid 30106484)
34. Shieh SY, Ikeda M, Taya Y, Prives C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334. (Pubitemid 27467963)
35. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG et al. (1996). Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 56:2703-2706. (Pubitemid 26175721)
36. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S et al. (2005). Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 65:1352-1360. (Pubitemid 40270162)
37. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408:307-310.
38. Waldman T, Kinzler KW, Vogelstein B. (1995). p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55:5187-5190.
39. Xu ZP, Tsuji T, Riordan JF, Hu GF. (2003). Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 42:121-128. (Pubitemid 36083858)
40. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG et al. (2002). Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259-263. (Pubitemid 34761289)